[{"question_number": "Q11", "question_text": "Which of the following statements is true regarding multiple sclerosis?", "options": {"A": "Activation of unmyelinated axons will result in Uhthoff phenomenon", "B": "It primarily affects the peripheral nervous system", "C": "It is caused by a viral infection", "D": "It is characterized by demyelination of motor neurons"}, "correct_answer": "A", "source_file": "Part 1 2020_mcqs.txt", "exam_type": "Part I", "exam_year": 2020, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q185", "question_text": "", "options": {"A": "Immune-mediated vascular endotheliopathy", "B": "Demyelination of central nervous system neurons", "C": "Autoimmune attack on myelin basic protein", "D": "Viral infection of the inner ear and brain"}, "correct_answer": "A", "source_file": "part 2 2024_mcqs.txt", "exam_type": "Part II", "exam_year": 2024, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q298", "question_text": "", "options": {"A": "patient with multiple sclerosis on fingolimod for a couple of years developed weakness and slurred speech. VZV test was positive, and his JCV before starting treatment was negative. What should be done next?"}, "correct_answer": "A", "source_file": "Promotion 2018_mcqs.txt", "exam_type": "Promotion", "exam_year": 2018, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q335", "question_text": "", "options": {"A": "Anti-NMDA receptor encephalitis", "B": "Opsoclonus myoclonus syndrome", "C": "Pilocytic astrocytoma", "D": "Medulloblastoma"}, "correct_answer": "A", "source_file": "Promotion 2022_mcqs.txt", "exam_type": "Promotion", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q133", "question_text": "", "options": {"A": "Amantadine", "B": "Modafinil", "C": "Methylphenidate", "D": "Physical exercise"}, "correct_answer": "A", "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt", "exam_type": "Part II", "exam_year": 2024, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q279", "question_text": "", "options": {"A": "child with a history of vaccination presents with confusion. What is the likely diagnosis?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q157", "question_text": "", "options": {"A": "Anti-Ri", "B": "Anti-NMDA", "C": "Anti-GAD", "D": "Anti-CRMP-1"}, "correct_answer": "A", "source_file": "Part I 2019_mcqs.txt", "exam_type": "Part I", "exam_year": 2019, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q161", "question_text": "Demyelination is commonly linked to which organism?", "options": {"A": "HIV", "B": "HHV-6", "C": "EBV", "D": "CMV"}, "correct_answer": "C", "source_file": "Part I 2022_mcqs.txt", "exam_type": "Part I", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q96", "question_text": "", "options": {"A": "woman who had an episode of nausea and vomiting, along with visual changes in both eyes at different times, now presents with symptoms of transverse myelitis (TM). What is the treatment?"}, "correct_answer": "A", "source_file": "Part 2 2020 copy_mcqs.txt", "exam_type": "Part II", "exam_year": 2020, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q168", "question_text": "", "options": {"A": "patient with relapsing-remitting multiple sclerosis (RRMS) has been stable on disease-modifying therapy (DMT) but stopped it 2 months ago as she wants to get pregnant. She presents with new MRI findings showing active enhancing brain lesions. What is the mechanism of the DMT that she was taking?"}, "correct_answer": "A", "source_file": "Part I 2022_mcqs.txt", "exam_type": "Part I", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q221", "question_text": "", "options": {"A": "10 - 20%", "B": "30 - 50%", "C": "44 - 93%", "D": "60 - 80%"}, "correct_answer": "C", "source_file": "Part II 2019_mcqs.txt", "exam_type": "Part II", "exam_year": 2019, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q149", "question_text": "", "options": {"A": "Number of attacks", "B": "Objective clinical evidence for the number of MS lesions", "C": "Family history of migraines", "D": "Brain MRI (with and without gadolinium)"}, "correct_answer": "C", "source_file": "Part I 2018_mcqs.txt", "exam_type": "Part I", "exam_year": 2018, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q146", "question_text": "", "options": {"A": "Relapses and remissions", "B": "Onset between ages 11 and 50 years", "C": "Progressive cognitive decline from onset", "D": "Absence of sensory symptoms"}, "correct_answer": "A", "source_file": "Part I 2018_mcqs.txt", "exam_type": "Part I", "exam_year": 2018, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q126", "question_text": "Young lady, with encephalopathy and hearing impairment, no visual symptoms mentioned, MRI attached showed corpus callosum lesions typical of snowball sign, asking about the pathophysiology of the diagnosis?", "options": {"A": "Microvascular endothelial proliferation damage", "B": "Demyelination of central nervous system neurons", "C": "Autoimmune-mediated peripheral nerve destruction", "D": "Neuronal mitochondrial dysfunction"}, "correct_answer": "A", "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt", "exam_type": "Part II", "exam_year": 2024, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q142", "question_text": "", "options": {"A": "middle-aged female presents with lower limb stiffness mainly affecting hip muscles and has lumbar hyperlordosis. What antibody is likely to be found?"}, "correct_answer": "A", "source_file": "Part I 2018_mcqs.txt", "exam_type": "Part I", "exam_year": 2018, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q251", "question_text": "", "options": {"A": "Fingolimod", "B": "Glatiramer acetate (GA)", "C": "Teriflunomide", "D": "Dimethyl fumarate (DF)"}, "correct_answer": "B", "source_file": "Part II 2019_mcqs.txt", "exam_type": "Part II", "exam_year": 2019, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q2", "question_text": "", "options": {"A": "HSV", "B": "EBV", "C": "CMV", "D": "VZV"}, "correct_answer": "B", "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt", "exam_type": "Part I", "exam_year": 2024, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q122", "question_text": "Patient was diagnosed with Multiple sclerosis and has psoriasis. What is an appropriate DMT for her case?", "options": {"A": "Dimethyl fumarate", "B": "Interferon beta-1a", "C": "Natalizumab", "D": "Fingolimod"}, "correct_answer": "A", "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt", "exam_type": "Part II", "exam_year": 2024, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q172", "question_text": "", "options": {"A": "patient with intractable vomiting and nausea was admitted under GI and investigated with no identifiable cause. An MRI was done. Which of the following is a core feature for the suspected diagnosis?"}, "correct_answer": "A", "source_file": "Part I 2023_mcqs.txt", "exam_type": "Part I", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q68", "question_text": "", "options": {"A": "1-2%", "B": "5-10%", "C": "15-20%", "D": "25-30%"}, "correct_answer": "D", "source_file": "Part 1 2021_mcqs.txt", "exam_type": "Part I", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q267", "question_text": "", "options": {"A": "Gabapentin", "B": "Carbamazepine", "C": "Baclofen", "D": "Diazepam"}, "correct_answer": "B", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q147", "question_text": "", "options": {"A": "female with a history of Type 1 diabetes mellitus presented with symptoms of axial and peripheral muscle stiffness. What antibodies are usually found in this condition?"}, "correct_answer": "A", "source_file": "Part I 2018_mcqs.txt", "exam_type": "Part I", "exam_year": 2018, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q138", "question_text": "Young lady presented with acute decrease in vision bilaterally, MRI brain done showed hyperintensity in optic nerve, rest of MRI was normal, what is the management? (case of optic neuritis)", "options": {"A": "IV methylprednisolone", "B": "Oral prednisone", "C": "Plasma exchange", "D": "Observation and follow-up"}, "correct_answer": "A", "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt", "exam_type": "Part II", "exam_year": 2024, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q362", "question_text": "", "options": {"A": "Anti-MA", "B": "Anti-GAD", "C": "Anti-NMDA", "D": "Anti-CRMP"}, "correct_answer": "B", "source_file": "part 2 2021 (2", "exam_type": "Part II", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q183", "question_text": "", "options": {"A": "Anti-NMDA receptor encephalitis", "B": "Viral encephalitis", "C": "Autoimmune encephalitis", "D": "Paraneoplastic encephalitis"}, "correct_answer": "C", "source_file": "Part II 2018_mcqs.txt", "exam_type": "Part II", "exam_year": 2018, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q364", "question_text": "", "options": {"A": "scenario presents a case of limbic encephalitis. What is the most likely diagnosis?"}, "correct_answer": "A", "source_file": "part 2 2021 (2", "exam_type": "Part II", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q266", "question_text": "", "options": {"A": "lady diagnosed with RRMS is about to start DMT. What will you give her?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q361", "question_text": "", "options": {"A": "female patient with a known case of multiple sclerosis (MS) came with increased sensory symptoms and mentioned a change in her urine smell. What is the diagnosis?"}, "correct_answer": "A", "source_file": "part 2 2021 (2", "exam_type": "Part II", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q16", "question_text": "An elderly patient presents with areflexia (tendon reflex not obtained), ophthalmoplegia, and impaired finger-to-nose test for the past 2 days, with no history of infection or vaccination. What is the next step in management?", "options": {"A": "IVIG", "B": "Methylprednisolone", "C": "Acetylcholine", "D": "Plasmapheresis"}, "correct_answer": "A", "source_file": "Sleep_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q23", "question_text": "", "options": {"A": "patient with relapsing-remitting multiple sclerosis (RRMS) and psoriasis started on disease-modifying therapy (DMT) and showed improvement in his psoriasis. What is the DMT?"}, "correct_answer": "A", "source_file": "Critical_Care_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q27", "question_text": "", "options": {"A": "patient on Natalizumab develops progressive multifocal leukoencephalopathy (PML). What is the appropriate management?"}, "correct_answer": "A", "source_file": "Sleep_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q28", "question_text": "", "options": {"A": "young man diagnosed with left eye optic neuritis was planned to start Teriflunomide. He has no previous history of neurological symptoms and is not interested in starting the treatment. Which of the following statements is true regarding the suspected differential diagnosis?"}, "correct_answer": "A", "source_file": "Neuroanatomy", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q29", "question_text": "", "options": {"A": "patient with multiple sclerosis (MS) on disease-modifying therapy (DMT) developed hyperthyroidism. What is the most likely medication used?"}, "correct_answer": "A", "source_file": "Neuroanatomy", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q38", "question_text": "", "options": {"A": "patient with a known case of Multiple Sclerosis used a medication that causes flushing. What is the mechanism of action of that drug?"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q41", "question_text": "", "options": {"A": "patient with multiple sclerosis developed tonic spasms. Which medication is most appropriate for treatment?"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q43", "question_text": "", "options": {"A": "35-year-old female patient, medically free, came with heat intolerance, lower limb weakness, and sensory symptoms, along with urinary incontinence. Her symptoms increased after stress at work. What will you do next?"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q58", "question_text": "", "options": {"A": "female patient with a known case of multiple sclerosis (MS) came with increased sensory symptoms and mentioned a change in her urine smell. What is the diagnosis?"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q60", "question_text": "", "options": {"A": "patient came with bilateral optic neuritis; MRI showed high signal intensity in the bilateral optic nerves. What is the diagnosis?"}, "correct_answer": "A", "source_file": "Sleep_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q64", "question_text": "What is the odds ratio for infectious mononucleosis as a risk factor for multiple sclerosis?", "options": {"A": "1.3", "B": "2.0", "C": "2.1", "D": "2.5"}, "correct_answer": "D", "source_file": "Neuroanatomy", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q67", "question_text": "", "options": {"A": "young lady known to have MS is pregnant and asks about the percentage risk of her baby having MS. What is the estimated risk?"}, "correct_answer": "A", "source_file": "Neuroanatomy", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q69", "question_text": "", "options": {"A": "patient with optic neuritis and one periventricular lesion is evaluated. What do the McDonald criteria indicate?"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q70", "question_text": "In neuromyelitis optica (NMO), which statement is correct?", "options": {"A": "It is 10 times more common in males than females", "B": "It is monophasic with no relapses", "C": "NMO lesions show immunoglobulin and complement deposits in a characteristic vasculo-concentric rim and rosette pattern around hyalinized blood vessels", "D": "It primarily affects the peripheral nervous system"}, "correct_answer": "C", "source_file": "Neuroanatomy", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q71", "question_text": "", "options": {"A": "case scenario about temporal arteritis presents the following: Age more than 50, presenting with headache and visual changes. If no ESR is done, what should be done next?"}, "correct_answer": "A", "source_file": "Neuroanatomy", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q76", "question_text": "What is the estimated risk of progressive multifocal leukoencephalopathy (PML) with rituximab?", "options": {"A": "1 in 10,000", "B": "1 in 30,000", "C": "1 in 50,000", "D": "1 in 100,000"}, "correct_answer": "A", "source_file": "Neuroanatomy", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q81", "question_text": "", "options": {"A": "young female has a history of left-sided weakness that lasted for 10 days and then improved. She now presents with fatigue. What is the most appropriate step of management for her current complaint?"}, "correct_answer": "A", "source_file": "Critical_Care_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q83", "question_text": "", "options": {"A": "patient known to have multiple sclerosis (MS) on natalizumab develops an infusion reaction. What is the most appropriate action?"}, "correct_answer": "A", "source_file": "Critical_Care_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q84", "question_text": "", "options": {"A": "patient diagnosed with multiple sclerosis (MS) is on treatment but shows no improvement, continuing to have recurrent attacks and an increase in disability. A detailed history reveals a recurrent history of dry eyes. What will you do?"}, "correct_answer": "A", "source_file": "Critical_Care_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q85", "question_text": "Which of the following indicates disease progression in Multiple Sclerosis (MS)?", "options": {"A": "Cerebral atrophy", "B": "Disability progression/number of relapses", "C": "New T2 lesions", "D": "All of the above"}, "correct_answer": "D", "source_file": "Critical_Care_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q111", "question_text": "", "options": {"A": "patient with multiple sclerosis developed a tremor. What is the most appropriate treatment?"}, "correct_answer": "A", "source_file": "Critical_Care_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q130", "question_text": "Which of the following antibodies is associated with myoclonus dystonia?", "options": {"A": "Anti-GD1", "B": "Anti-GB1", "C": "Anti-GM1", "D": "Anti-GAD65"}, "correct_answer": "B", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q141", "question_text": "MS pathophysiology is most commonly associated with which of the following?", "options": {"A": "EBV", "B": "Vitamin B12", "C": "HHV-6", "D": "Herpes Simplex Virus"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q142", "question_text": "Which risk factor has an odds ratio of 0.5 and is considered unknown in its association with multiple sclerosis?", "options": {"A": "Oral tobacco", "B": "Coffee", "C": "Alcohol", "D": "Passive smoking"}, "correct_answer": "C", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q166", "question_text": "An MS patient developed a tremor. What is the recommended treatment?", "options": {"A": "Propranolol", "B": "Levodopa", "C": "Carbamazepine", "D": "Baclofen"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q176", "question_text": "", "options": {"A": "young female presented with unilateral optic neuritis features. She has positive oligoclonal bands (OCB) and brain MRI shows one enhancing lesion. According to the 2017 McDonald\u2019s criteria, what is her diagnosis?"}, "correct_answer": "A", "source_file": "Neuromuscular", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q186", "question_text": "", "options": {"A": "young patient with multiple new acute strokes on MRI has a history of sensorineural hearing loss. What condition is suspected?"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q204", "question_text": "", "options": {"A": "34-year-old male presents with myoclonus and abnormal eye movements. What is the most likely underlying condition?"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q208", "question_text": "In a case of testicular cancer, which antibody is most likely to be present?", "options": {"A": "Anti-MA", "B": "Anti-GAD", "C": "Anti-NMDA", "D": "Anti-CRMP"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q210", "question_text": "", "options": {"A": "patient with optic neuritis and one periventricular lesion. What is her McDonald criteria?"}, "correct_answer": "A", "source_file": "Movement_Disorders", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q274", "question_text": "", "options": {"A": "female patient came with relapsing-remitting multiple sclerosis (RRMS) and an attached MRI of the brain and spine. What is the mechanism of the disease?"}, "correct_answer": "A", "source_file": "Neuromuscular", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q275", "question_text": "", "options": {"A": "patient diagnosed with multiple sclerosis (MS) continues to experience relapses despite starting disease-modifying therapy (DMT). The spinal cord MRI shows a \"trident sign.\" What is the most likely diagnosis?"}, "correct_answer": "A", "source_file": "Neuromuscular", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q319", "question_text": "", "options": {"A": "patient with a long history of multiple sclerosis presents with fatigue. What medication would you consider as a first-line treatment?"}, "correct_answer": "A", "source_file": "Neuromuscular", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q451", "question_text": "", "options": {"A": "patient receiving their third infusion of Natalizumab develops an allergy with shortness of breath. What should be done?"}, "correct_answer": "A", "source_file": "Neuromuscular", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q3", "question_text": "", "options": {"A": "lady known to have multiple sclerosis (MS) presents with a history of leg numbness for one year. She is currently on teriflunomide but shows no improvement. What is the next appropriate step in her management?"}, "correct_answer": "A", "source_file": "Sleep_Neurology", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q118", "question_text": "Which factor is associated with a worse prognosis in multiple sclerosis (MS)?", "options": {"A": "Male sex", "B": "Female sex", "C": "Age at onset", "D": "Initial symptoms"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q220", "question_text": "Patient came with focal seizure with secondary generalization; he has focal atrophy in the brain; what is the antibody associated with this disease?", "options": {"A": "GluR3", "B": "NMDA receptor", "C": "LGI1", "D": "CASPR2"}, "correct_answer": "A", "source_file": "part 2 2021 (2", "exam_type": "Part II", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q115", "question_text": "In a paraneoplastic case, what should be done next?", "options": {"A": "Treat underlying etiology", "B": "Initiate immunotherapy", "C": "Perform symptomatic management", "D": "Monitor neurological status closely"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q103", "question_text": "", "options": {"A": "patient with relapsing-remitting multiple sclerosis (RRMS) received 5 days of intravenous methylprednisolone (IVMP) without improvement. What should be done next?"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q279", "question_text": "An MS patient developed tonic spasms. What is the appropriate treatment?", "options": {"A": "Carbamazepine", "B": "Baclofen", "C": "Gabapentin", "D": "Diazepam"}, "correct_answer": "A", "source_file": "part 2 2021 (2", "exam_type": "Part II", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q104", "question_text": "", "options": {"A": "patient with multiple sclerosis experiences painful muscle spasms multiple times per day. Which medication is commonly used for this condition?"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q69", "question_text": "Which of the following indicates disease progression in multiple sclerosis (MS)?", "options": {"A": "Brain atrophy", "B": "T2 lesions", "C": "Lesion enhancement", "D": "New clinical relapses"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q193", "question_text": "", "options": {"A": "patient presented with focal seizures that progressed to complex partial seizures and multiple episodes of status epilepticus with hemiparesis. MRI showed hemispheric perisylvian atrophy. What will you send for?"}, "correct_answer": "A", "source_file": "Part I 2019_mcqs.txt", "exam_type": "Part I", "exam_year": 2019, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q79", "question_text": "Patient came with focal seizure with secondary generalization; he has focal atrophy in the brain. What is the antibody associated with this disease?", "options": {"A": "GluR3", "B": "NMDA receptor", "C": "LGI1", "D": "GAD65"}, "correct_answer": "A", "source_file": "Part 2 2021_mcqs.txt", "exam_type": "Part II", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q124", "question_text": "In a scenario involving diabetes mellitus with stiff person syndrome, what is the most likely antibody present?", "options": {"A": "Anti-GAD", "B": "Anti-NMDA receptor", "C": "Anti-Aquaporin-4", "D": "Anti-MOG"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q87", "question_text": "Which condition is based on astrocyte pathology?", "options": {"A": "NMOSD", "B": "Anti-MOG", "C": "Multiple sclerosis", "D": "Acute disseminated encephalomyelitis"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q88", "question_text": "What is known about the pathology of multiple sclerosis (MS)?", "options": {"A": "Diffuse white matter disease and focal grey matter involvement", "B": "Grey matter disease may be related to a progressive course", "C": "Both A and B", "D": "None of the above"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q49", "question_text": "", "options": {"A": "patient presents with onset of right optic neuritis. MRI of the brain shows a brain stem lesion that is possibly enhancing and periventricular non-enhancing. What can be said about dissemination in time and space?"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q129", "question_text": "", "options": {"A": "patient has worsening neurological symptoms for 3 years with positive oligoclonal bands (OCB). What is the treatment for primary progressive multiple sclerosis (PPMS)?"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q247", "question_text": "", "options": {"A": "24-year-old female patient presents with fever and symptoms of meningitis, along with psychiatric manifestations. Her HSV PCR is positive, and MRI shows temporal lobe petechial hemorrhage with encephalomalacia. After treatment, she improves but then has a seizure. What is the cause of the seizure?"}, "correct_answer": "A", "source_file": "Promotion 2019_mcqs.txt", "exam_type": "Promotion", "exam_year": 2019, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q117", "question_text": "", "options": {"A": "patient with RRMS on Natalizumab presents with worsening lower limb weakness and blurred vision over 2 months. What is the next step in management?"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q405", "question_text": "What is the next step to confirm small vessel CNS vasculitis?", "options": {"A": "Brain Biopsy", "B": "Conventional Angiography", "C": "MRA", "D": "Intracranial Doppler"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q82", "question_text": "In a long scenario for a patient with neuropathy and asthma, what is the next step in management?", "options": {"A": "ANCA testing for Churg-Strauss syndrome", "B": "Nerve conduction studies", "C": "High-dose corticosteroids", "D": "Chest X-ray"}, "correct_answer": "A", "source_file": "Part 2 2020 copy_mcqs.txt", "exam_type": "Part II", "exam_year": 2020, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q205", "question_text": "In the scenario of Susac syndrome, which of the following findings can be seen on MRI?", "options": {"A": "High signals in the corpus callosum", "B": "Atrophy of the cerebellum", "C": "Lesions in the brainstem", "D": "No significant findings"}, "correct_answer": "A", "source_file": "Part II 2018_mcqs.txt", "exam_type": "Part II", "exam_year": 2018, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q541", "question_text": "What is the first-line treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?", "options": {"A": "IV Immunoglobulin (IVIG)", "B": "Plasmapheresis", "C": "Corticosteroids", "D": "Antidepressants"}, "correct_answer": "A", "source_file": "part 2 2021 (2", "exam_type": "Part II", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q440", "question_text": "", "options": {"A": "patient has stiffness and neuromyotonia on EMG, recurrent loss of consciousness, but is currently stable. He has positive potassium antibodies. What is the diagnosis?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q13", "question_text": "In the same case of Mononeuritis Multiplex with weight loss and fever, what is the most appropriate treatment?", "options": {"A": "Cyclophosphamide", "B": "Azathioprine", "C": "Cyclosporine", "D": "Methotrexate"}, "correct_answer": "A", "source_file": "Part 2 - 2023_mcqs.txt", "exam_type": "Part II", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q8", "question_text": "", "options": {"A": "patient with MS on medication presents with blurry vision and macular edema. What medication is likely responsible?"}, "correct_answer": "A", "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt", "exam_type": "Part I", "exam_year": 2024, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q358", "question_text": "", "options": {"A": "lady with sleep disturbances and increased sleep has an MRI showing diencephalic hyperintensity. What will you do?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q122", "question_text": "", "options": {"A": "patient with symptoms suggestive of chronic inflammatory demyelinating polyneuropathy (CIDP) was not responding to intravenous immunoglobulin (IVIG) and was found to have positive neurofascin 155 antibodies. What is the pathophysiology of these antibodies?"}, "correct_answer": "A", "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt", "exam_type": "Part II", "exam_year": 2024, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q336", "question_text": "", "options": {"A": "female with a history of systemic lupus erythematosus (SLE) presents with a scenario suggestive of cavernous sinus syndrome, no fever, and a brain CT that is unremarkable. What is the next step in management?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q197", "question_text": "", "options": {"A": "young patient in his 30s presented to the emergency room with limb weakness that started one week ago. He has a history of pharyngitis 6 weeks ago and was treated with antibiotics. After that, he started to complain of difficulty swallowing and change in voice. Then he developed weakness involving all four limbs. On physical examination, he has bilateral flaccid weakness with absent reflexes. Which of the following is the pathophysiology responsible for the patient\u2019s diagnosis (likely Guillain-Barr\u00e9 Syndrome)?"}, "correct_answer": "A", "source_file": "Part I 2023_mcqs.txt", "exam_type": "Part I", "exam_year": 2023, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q204", "question_text": "In patients treated with natalizumab, which of the following is considered a risk factor for developing PML?", "options": {"A": "Low index of JC virus in serum", "B": "High index of JC virus in serum", "C": "Previous history of migraines", "D": "Age over 60 years"}, "correct_answer": "B", "source_file": "Part II 2018_mcqs.txt", "exam_type": "Part II", "exam_year": 2018, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q84", "question_text": "An MS patient presents with tonic spasms. What is the treatment?", "options": {"A": "Carbamazepine", "B": "Clonazepam", "C": "Baclofen", "D": "Gabapentin"}, "correct_answer": "A", "source_file": "Part 2 2021_mcqs.txt", "exam_type": "Part II", "exam_year": 2021, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q279", "question_text": "Which of the following cranial nerves is primarily responsible for controlling the muscles of mastication?", "options": {"A": "Facial nerve (VII)", "B": "Trigeminal nerve (V)", "C": "Glossopharyngeal nerve (IX)", "D": "Hypoglossal nerve (XII)"}, "correct_answer": "B", "source_file": "", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q378", "question_text": "", "options": {"A": "patient with a history of MS relapse 3 weeks ago while on interferon presents with worsening weakness for 2 days. What should be the next step in management?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q338", "question_text": "", "options": {"A": "patient with multiple sclerosis (MS) is experiencing fatigue but has stable disease and no mood symptoms. What is the most appropriate treatment?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q295", "question_text": "", "options": {"A": "female patient had optic neuritis with one non-enhancing periventricular lesion. According to McDonald's criteria and with Oligoclonal Bands negative, what is the diagnosis?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q49", "question_text": "Which of the following cranial nerves is primarily responsible for the sense of smell?", "options": {"A": "Optic nerve (CN II)", "B": "Olfactory nerve (CN I)", "C": "Trigeminal nerve (CN V)", "D": "Facial nerve (CN VII)"}, "correct_answer": "B", "source_file": "", "exam_type": null, "exam_year": null, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q357", "question_text": "", "options": {"A": "female patient with a known case of multiple sclerosis (MS) shows MRI findings consistent with neuromyelitis optica (NMO). What is the underlying pathophysiology?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q415", "question_text": "", "options": {"A": "female patient with optic neuritis and multiple MRI lesions but no activity, who also has psoriasis, what is the appropriate DMT for her?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}, {"question_number": "Q318", "question_text": "", "options": {"A": "long scenario describes a lady who came with optic neuritis and had papilledema. What will you send for her?"}, "correct_answer": "A", "source_file": "Part II 2022_mcqs.txt", "exam_type": "Part II", "exam_year": 2022, "subspecialty": "Neuroimmunology", "explanation": ""}]